FACTORS LINKED WITH PSYCHOLOGICAL DISTRESS IN A DIVERSE SAMPLE OF SUBSTANCE-USING ADULTS IN THE SOUTHEASTERN U.S.

Autor: Ahmed, A, Hernandez, MT, Padilla, AS, Laschober, TC, Hatch, M, Paschen-Wolff, M, Wright, L, Tross, S, Ertl, MM.

Publikováno v: In Drug and Alcohol Dependence 1 August 2024 261 Supplement

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma

Autor: Goicoechea I, Puig N, Cedena MT, Burgos L, Cordón L, Vidriales MB, Flores-Montero J, Gutierrez NC, Calasanz MJ, Martin Ramos ML, Lara-Astiaso D, Vilas-Zornoza A, Alignani D, Rodriguez I, Sarvide S, Alameda D, Garcés JJG, Rodriguez S, Fresquet V, Celay J, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Rios R, Martin-Sanchez J, Martinez-Martinez R, Sarra J, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Martinez-Climent JA, Orfao A, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel J, Paiva B

Publikováno v: Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Patients with multiple myeloma (MM) carrying high-risk cytogenetic abnormalities (CA) have inferior outcome despite achieving similar complete response (CR) rates when compared to cases with standard-risk CA. This questions the legitimacy of CR as tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::662afeb5374b7f68370e2620b1ad0a33
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13310

Biological and clinical signi fi cance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

Autor: Maia, C, Puig, N, Cedena, MT, Goicoechea, I, Valdes-Mas, R, Vazquez, I, Chillon, MC, Aguirre, P, Sarvide, S, Gracia-Aznarez, FJ, Alkorta, G, Calasanz, MJ, Garcia-Sanz, R, Gonzalez, M, Gutierrez, NC, Martinez-Lopez, J, Perez, JJ, Merino, J, Moreno, C, Burgos, L, Alignani, D, Botta, C, Prosper, F, Matarraz, S, Orfao, A, Oriol, A, Teruel, AI, de Paz, RD, de Arriba, F, Hernandez, MT, Palomera, L, Martinez, R, Rosinol, L, Mateos, MV, Lahuerta, JJ, Blade, J, San Miguel, JF, Paiva, B

Publikováno v: Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Risk of developing myelodysplastic syndrome (MDS) is significantly increased in both multiple myeloma (MM) and monoclonal gammopathy of undetermined significance, suggesting that it is therapy independent. However, the incidence and sequelae of dys-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9918179de2587a18ddfb1c22d801da5d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4692

The National Institutes of Health Fogarty International Center Global Health Scholars and Fellows Program: Collaborating Across Five Consortia to Strengthen Research Training

Autor: Zunt, JR, Chi, BH, Heimburger, DC, Cohen, CR, Strathdee, S, Hobbs, N, Thomas, Y, Bale, K, Salisbury, K, Hernandez, MT, Riley, LW, Vermund, SH, Van Der Horst, C

Publikováno v: The American journal of tropical medicine and hygiene, vol 95, iss 3
Zunt, JR; Chi, BH; Heimburger, DC; Cohen, CR; Strathdee, S; Hobbs, N; et al.(2016). The National Institutes of Health Fogarty International Center global health scholars and fellows program: Collaborating across five consortia to strengthen research training. American Journal of Tropical Medicine and Hygiene, 95(3), 728-734. doi: 10.4269/ajtmh.16-0190. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/7t4581hg

© Copyright 2016 by The American Society of Tropical Medicine and Hygiene. As demand for global health research training continues to grow, many universities are striving to meet the needs of trainees in a manner complementary to research priorities

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9975d06105929df9fa5fbd43f55557fd

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Autor: Rosinol, L, Oriol, A, Teruel, AI, Hernandez, D, Lopez-Jimenez, J, de la Rubia, J, Granell, M, Besalduch, J, Palomera, L, Gonzalez, Y, Etxebeste, MA, Diaz-Mediavilla, J, Hernandez, MT, de Arriba, F, Gutierrez, NC, Martin-Ramos, ML, Cibeira, MT, Mateos, MV, Martinez, J, Alegre, A, Lahuerta, JJ, San Miguel, J, Blade, J

Publikováno v: BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine, BCNU, melphalan, cyclophosphamide, prednisone/vincristine, BCNU, doxorubicin, dexamethasone/bo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b510ece8490f586195c364962ac8787a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11166